Extra Alirocumab in Addition to Statin Therapy in Symptomatic IntraCranial Atherosclerotic Stenosis ----a Pilot Study

NCT06052020 · clinicaltrials.gov ↗

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Stroke
Intracranial Atherosclerotic Stenosis

Interventions

DRUG: Alirocumab
DRUG: Atorvastatin

Sponsor

The First Affiliated Hospital with Nanjing Medical University